• Home Blog Tag Metastatic triple negative breast cancer

Metastatic Triple Negative Breast Cancer

pharma-news-for-regeneron-gilead-neuronos

Apr 22, 2025

FDA Approves Sanofi/Regeneron’s DUPIXENT as First New CSU Therapy in Over a Decade; Gilead’s TRODELVY + KEYTRUDA Shows PFS Benefit in PD-L1+ TNBC; Tempest’s TPST-1495 Gets FDA Orphan Tag for FAP; uniQure’s AMT-130 Granted FDA Breakthrough for Huntington’s; NeuroNOS’ BA-102 Secures FDA Orphan Status for Phelan-McDermid Syndrome

truqap-for-tnbc-treatment

Jun 25, 2024

AstraZeneca’s AKT Inhibitor TRUQAP Falls Short in Triple Negative Breast Cancer

trop2-inhibitors-for-cancer-treatment

Mar 15, 2024

Unveiling the Potential of TROP-2 Inhibitors: A New Frontier in Cancer Treatment

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper